Stromal Co-Cultivation for Modeling Breast Cancer Dormancy in the Bone Marrow
Overview
Authors
Affiliations
Cancers metastasize to the bone marrow before primary tumors can be detected. Bone marrow micrometastases are resistant to therapy, and while they are able to remain dormant for decades, they recur steadily and result in incurable metastatic disease. The bone marrow microenvironment maintains the dormancy and chemoresistance of micrometastases through interactions with multiple cell types and through structural and soluble factors. Modeling dormancy in vitro can identify the mechanisms of these interactions. Modeling also identifies mechanisms able to disrupt these interactions or define novel interactions that promote the reawakening of dormant cells. The in vitro modeling of the interactions of cancer cells with various bone marrow elements can generate hypotheses on the mechanisms that control dormancy, treatment resistance and reawakening in vivo. These hypotheses can guide in vivo murine experiments that have high probabilities of succeeding in order to verify in vitro findings while minimizing the use of animals in experiments. This review outlines the existing data on predominant stromal cell types and their use in 2D co-cultures with cancer cells.
Bone Marrow Stroma Co-cultivation Model of Breast Cancer Dormancy.
Wieder R Methods Mol Biol. 2024; 2811:55-67.
PMID: 39037649 DOI: 10.1007/978-1-0716-3882-8_4.
Outlook and opportunities for engineered environments of breast cancer dormancy.
Richbourg N, Irakoze N, Kim H, Peyton S Sci Adv. 2024; 10(10):eadl0165.
PMID: 38457510 PMC: 10923521. DOI: 10.1126/sciadv.adl0165.
Patient-Derived Organoids as Therapy Screening Platforms in Cancer Patients.
Khorsandi D, Yang J, Foster S, Khosravi S, Kouchehbaghi N, Zarei F Adv Healthc Mater. 2024; 13(21):e2302331.
PMID: 38359321 PMC: 11324859. DOI: 10.1002/adhm.202302331.
Awakening of Dormant Breast Cancer Cells in the Bone Marrow.
Wieder R Cancers (Basel). 2023; 15(11).
PMID: 37296983 PMC: 10252003. DOI: 10.3390/cancers15113021.
Fibroblasts as Turned Agents in Cancer Progression.
Wieder R Cancers (Basel). 2023; 15(7).
PMID: 37046676 PMC: 10093070. DOI: 10.3390/cancers15072014.